CYP2B6 polymorphisms and nevirapine and efavirenz DILI

被引：0
|
作者：
机构：
来源：
Reactions Weekly | 2024年 / 2037卷 / 1期
关键词：
D O I：
10.1007/s40278-024-71697-7
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：4 / 4
相关论文
共 50 条
  • [1] Underlying genetic structure impacts the association between CYP2B6 polymorphisms and response to efavirenz and nevirapine
    Frasco, Melissa A.
    Mack, Wendy J.
    Van Den Berg, David
    Aouizerat, Bradley E.
    Anastos, Kathryn
    Cohen, Mardge
    De Hovitz, Jack
    Golub, Elizabeth T.
    Greenblatt, Ruth M.
    Liu, Chenglong
    Conti, David V.
    Pearce, Celeste L.
    AIDS, 2012, 26 (16) : 2097 - 2106
  • [2] Associations between CYP2B6 Polymorphisms and Pharmacokinetics after a Single Dose of Nevirapine or Efavirenz in African Americans
    Haas, David W.
    Gebretsadik, Tebeb
    Mayo, Gail
    Menon, Usha N.
    Acosta, Edward P.
    Shintani, Ayumi
    Floyd, Michael
    Stein, C. Michael
    Wilkinson, Grant R.
    JOURNAL OF INFECTIOUS DISEASES, 2009, 199 (06): : 872 - 880
  • [3] Novel CYP2B6 polymorphisms and their impact on efavirenz and bupropion metabolism
    Klein, K.
    Radloff, R.
    Gras, A.
    Masquelier, C.
    Arumugam, K.
    Karasi, J-C
    Seguin-Devaux, C.
    Zanger, U. M.
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2013, 386 : S41 - S41
  • [4] CYP2B6 GENETIC VARIATION AND EFAVIRENZ AUTOINDUCTION INFLUENCES CYP2B6 A ACTIVITY AND EFAVIRENZ EXPOSURE IN HEALTHY VOLUNTEERS
    Metzger, I. F.
    Lu, J. B.
    Kreutz, Y.
    Thong, N.
    Flockhart, D. A.
    Desta, Z.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2013, 93 : S80 - S80
  • [5] CYP2B6 poor metaboliser alleles involved in efavirenz and nevirapine metabolism: CYP2B6*9 and CYP2B6*18 distribution in HIV-exposed subjects from Dschang, Western Cameroon
    Paganotti, Giacomo Maria
    Russo, Gianluca
    Sobze, Martin Sanou
    Mayaka, George Bouting
    Muthoga, Charles Waithaka
    Tawe, Leabaneng
    Martinelli, Axel
    Romano, Rita
    Vullo, Vincenzo
    INFECTION GENETICS AND EVOLUTION, 2015, 35 : 122 - 126
  • [6] Pharmacogenetics of CYP2B6, CYP2A6 and UGT2B7 in HIV treatment in African populations: focus on efavirenz and nevirapine
    Colic, Antoinette
    Alessandrini, Marco
    Pepper, Michael S.
    DRUG METABOLISM REVIEWS, 2015, 47 (02) : 111 - 123
  • [7] The impact of CYP2B6 polymorphisms on the interactions of efavirenz with lumefantrine: Implications for paediatric antimalarial therapy
    Zakaria, Zaril
    Badhan, Raj K. S.
    EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2018, 119 : 90 - 101
  • [8] Crystal Structure of CYP2B6 in Complex with an Efavirenz Analog
    Shah, Manish B.
    Zhang, Qinghai
    Halpert, James R.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2018, 19 (04)
  • [9] Efavirenz intoxication due to a new CYP2B6 constellation
    Anagnostopoulos, Alexia
    Rotger, Margalida
    Aouri, Manel
    Kuster, Stefan P.
    Telenti, Amalio
    Decosterd, Laurent A.
    Guenthard, Huldrych F.
    ANTIVIRAL THERAPY, 2013, 18 (05) : 739 - 743
  • [10] Effects of CYP2B6 polymorphisms on plasma nevirapine concentrations: a systematic review and meta-analysis
    Ha Young Yoon
    Young Ah Cho
    Jeong Yee
    Hye Sun Gwak
    Scientific Reports, 10
12345